Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - CASH FROM OPERATIONS
Cash from Operations TRVI - Trevi Therapeutics, Inc.
-31.7 M
LAST VALUE
-4.67%
2 YEAR CAGR
-11.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR